25, 4% i valsartan- gruppen) blev observeret for de patienter, der fik tredobbelt kombination af en ACE- hæmmer, en beta- blokker og valsartan.
25.4% in valsartan group) were observed for those patients receiving the triple combination of an ACE inhibitor, a beta blocker and valsartan.